358 related articles for article (PubMed ID: 37751026)
21. Cuproptosis-a potential target for the treatment of osteoporosis.
Li D; Gao Z; Li Q; Liu X; Liu H
Front Endocrinol (Lausanne); 2023; 14():1135181. PubMed ID: 37214253
[TBL] [Abstract][Full Text] [Related]
22. Roles and mechanisms of copper transporting ATPases in cancer pathogenesis.
Zhang Y; Li M; Yao Q; Chen C
Med Sci Monit; 2009 Jan; 15(1):RA1-5. PubMed ID: 19114980
[TBL] [Abstract][Full Text] [Related]
23. The Tao of copper metabolism: from physiology to pathology.
Gao S; Zhou M; Tang Z
Curr Med Chem; 2023 Sep; ():. PubMed ID: 37718523
[TBL] [Abstract][Full Text] [Related]
24. Cuproptosis and its application in different cancers: an overview.
Xu L; Liu K; Wang F; Su Y
Mol Cell Biochem; 2023 Dec; 478(12):2683-2693. PubMed ID: 36914880
[TBL] [Abstract][Full Text] [Related]
25. Connecting copper and cancer: from transition metal signalling to metalloplasia.
Ge EJ; Bush AI; Casini A; Cobine PA; Cross JR; DeNicola GM; Dou QP; Franz KJ; Gohil VM; Gupta S; Kaler SG; Lutsenko S; Mittal V; Petris MJ; Polishchuk R; Ralle M; Schilsky ML; Tonks NK; Vahdat LT; Van Aelst L; Xi D; Yuan P; Brady DC; Chang CJ
Nat Rev Cancer; 2022 Feb; 22(2):102-113. PubMed ID: 34764459
[TBL] [Abstract][Full Text] [Related]
26. Copper homeostasis and cuproptosis in health and disease.
Chen L; Min J; Wang F
Signal Transduct Target Ther; 2022 Nov; 7(1):378. PubMed ID: 36414625
[TBL] [Abstract][Full Text] [Related]
27. Cuproptosis, the novel therapeutic mechanism for heart failure: a narrative review.
Yuan HJ; Xue YT; Liu Y
Cardiovasc Diagn Ther; 2022 Oct; 12(5):681-692. PubMed ID: 36329965
[TBL] [Abstract][Full Text] [Related]
28. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
[TBL] [Abstract][Full Text] [Related]
29. Copper in diseases and treatments, and copper-based anticancer strategies.
Tisato F; Marzano C; Porchia M; Pellei M; Santini C
Med Res Rev; 2010 Jul; 30(4):708-49. PubMed ID: 19626597
[TBL] [Abstract][Full Text] [Related]
30. Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy.
Zheng P; Zhou C; Lu L; Liu B; Ding Y
J Exp Clin Cancer Res; 2022 Sep; 41(1):271. PubMed ID: 36089608
[TBL] [Abstract][Full Text] [Related]
31. Copper metabolism and hepatocellular carcinoma: current insights.
Zhou C; Yang J; Liu T; Jia R; Yang L; Sun P; Zhao W
Front Oncol; 2023; 13():1186659. PubMed ID: 37476384
[TBL] [Abstract][Full Text] [Related]
32. Targeting copper in cancer therapy: 'Copper That Cancer'.
Denoyer D; Masaldan S; La Fontaine S; Cater MA
Metallomics; 2015 Nov; 7(11):1459-76. PubMed ID: 26313539
[TBL] [Abstract][Full Text] [Related]
33. Is copper chelation an effective anti-angiogenic strategy for cancer treatment?
Antoniades V; Sioga A; Dietrich EM; Meditskou S; Ekonomou L; Antoniades K
Med Hypotheses; 2013 Dec; 81(6):1159-63. PubMed ID: 24210000
[TBL] [Abstract][Full Text] [Related]
34. Copper Complexes in Cancer Therapy.
Denoyer D; Clatworthy SAS; Cater MA
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394035
[TBL] [Abstract][Full Text] [Related]
35. Cuproptosis engages in c-Myc-mediated breast cancer stemness.
Wang R; Xu K; Chen Q; Hu Q; Zhang J; Guan X
J Transl Med; 2023 Jun; 21(1):409. PubMed ID: 37353799
[TBL] [Abstract][Full Text] [Related]
36. Copper and Diabetes: Current Research and Prospect.
Chang W; Li P
Mol Nutr Food Res; 2023 Dec; 67(23):e2300468. PubMed ID: 37863813
[TBL] [Abstract][Full Text] [Related]
37. The Molecular Mechanisms of Defective Copper Metabolism in Diabetic Cardiomyopathy.
Cui X; Wang Y; Liu H; Shi M; Wang J; Wang Y
Oxid Med Cell Longev; 2022; 2022():5418376. PubMed ID: 36238639
[TBL] [Abstract][Full Text] [Related]
38. Role of cuproptosis in understanding diseases.
Cao S; Wang Q; Sun Z; Zhang Y; Liu Q; Huang Q; Ding G; Jia Z
Hum Cell; 2023 Jul; 36(4):1244-1252. PubMed ID: 37154876
[TBL] [Abstract][Full Text] [Related]
39. Radiocopper for the imaging of copper metabolism.
Hueting R
J Labelled Comp Radiopharm; 2014 Apr; 57(4):231-8. PubMed ID: 24634197
[TBL] [Abstract][Full Text] [Related]
40. Novel copper complexes as potential proteasome inhibitors for cancer treatment (Review).
Zhang Z; Wang H; Yan M; Wang H; Zhang C
Mol Med Rep; 2017 Jan; 15(1):3-11. PubMed ID: 27959411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
